HUT67836A - Pyridazinone acetic acids having aldose reductase inhibitory activity, pharmaceutical compositions containing them and process for preparation of them - Google Patents
Pyridazinone acetic acids having aldose reductase inhibitory activity, pharmaceutical compositions containing them and process for preparation of them Download PDFInfo
- Publication number
- HUT67836A HUT67836A HU9302728A HU9302728A HUT67836A HU T67836 A HUT67836 A HU T67836A HU 9302728 A HU9302728 A HU 9302728A HU 9302728 A HU9302728 A HU 9302728A HU T67836 A HUT67836 A HU T67836A
- Authority
- HU
- Hungary
- Prior art keywords
- methyl
- formula
- oxo
- dihydro
- acetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67691991A | 1991-03-28 | 1991-03-28 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9302728D0 HU9302728D0 (en) | 1993-12-28 |
| HUT67836A true HUT67836A (en) | 1995-05-29 |
Family
ID=24716565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9302728A HUT67836A (en) | 1991-03-28 | 1992-03-09 | Pyridazinone acetic acids having aldose reductase inhibitory activity, pharmaceutical compositions containing them and process for preparation of them |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0582643A1 (enExample) |
| JP (1) | JPH06500793A (enExample) |
| CN (1) | CN1065269A (enExample) |
| AU (1) | AU658887B2 (enExample) |
| BR (1) | BR9205810A (enExample) |
| CA (1) | CA2107104A1 (enExample) |
| CZ (1) | CZ387092A3 (enExample) |
| DE (1) | DE9290035U1 (enExample) |
| FI (1) | FI934222A0 (enExample) |
| HU (1) | HUT67836A (enExample) |
| IE (1) | IE920979A1 (enExample) |
| IL (1) | IL101325A0 (enExample) |
| MX (1) | MX9201414A (enExample) |
| NZ (1) | NZ242152A (enExample) |
| PT (1) | PT100301A (enExample) |
| TW (1) | TW207998B (enExample) |
| WO (1) | WO1992017446A2 (enExample) |
| YU (1) | YU30392A (enExample) |
| ZA (1) | ZA922238B (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2240657T3 (es) | 2001-02-28 | 2005-10-16 | Pfizer Products Inc. | Compuestos de sulfonilpiridazinona utiles como inhibidores de aldosa reductasa. |
| SE0100873D0 (sv) * | 2001-03-13 | 2001-03-13 | Astrazeneca Ab | Method of treatment |
| ATE352551T1 (de) | 2001-03-30 | 2007-02-15 | Pfizer Prod Inc | Pyridazinon aldose reductase inhibitoren |
| AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| CN111617072B (zh) * | 2019-02-27 | 2023-06-20 | 苏州凯祥生物科技有限公司 | 一种高尿酸血症药物组合物及用于治疗高尿酸血症的药物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
| FR2647676A1 (fr) * | 1989-06-05 | 1990-12-07 | Union Pharma Scient Appl | Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase |
-
1992
- 1992-03-09 FI FI934222A patent/FI934222A0/fi not_active Application Discontinuation
- 1992-03-09 JP JP4509938A patent/JPH06500793A/ja active Pending
- 1992-03-09 WO PCT/US1992/001603 patent/WO1992017446A2/en not_active Ceased
- 1992-03-09 CA CA002107104A patent/CA2107104A1/en not_active Abandoned
- 1992-03-09 CZ CS923870A patent/CZ387092A3/cs unknown
- 1992-03-09 BR BR9205810A patent/BR9205810A/pt not_active Application Discontinuation
- 1992-03-09 DE DE9290035U patent/DE9290035U1/de not_active Expired - Lifetime
- 1992-03-09 AU AU17796/92A patent/AU658887B2/en not_active Ceased
- 1992-03-09 EP EP92910955A patent/EP0582643A1/en not_active Withdrawn
- 1992-03-09 HU HU9302728A patent/HUT67836A/hu unknown
- 1992-03-13 TW TW081101914A patent/TW207998B/zh active
- 1992-03-22 IL IL101325A patent/IL101325A0/xx unknown
- 1992-03-26 YU YU30392A patent/YU30392A/sh unknown
- 1992-03-26 PT PT100301A patent/PT100301A/pt not_active Application Discontinuation
- 1992-03-27 CN CN92102224A patent/CN1065269A/zh active Pending
- 1992-03-27 IE IE097992A patent/IE920979A1/en not_active Application Discontinuation
- 1992-03-27 NZ NZ24215292A patent/NZ242152A/en unknown
- 1992-03-27 ZA ZA922238A patent/ZA922238B/xx unknown
- 1992-03-27 MX MX9201414A patent/MX9201414A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IE920979A1 (en) | 1992-10-07 |
| BR9205810A (pt) | 1994-06-28 |
| TW207998B (enExample) | 1993-06-21 |
| WO1992017446A3 (en) | 1992-11-26 |
| MX9201414A (es) | 1992-10-01 |
| YU30392A (sh) | 1994-11-15 |
| PT100301A (pt) | 1993-06-30 |
| CN1065269A (zh) | 1992-10-14 |
| FI934222L (fi) | 1993-09-27 |
| CZ387092A3 (en) | 1994-02-16 |
| NZ242152A (en) | 1994-07-26 |
| CA2107104A1 (en) | 1992-09-29 |
| FI934222A7 (fi) | 1993-09-27 |
| WO1992017446A2 (en) | 1992-10-15 |
| ZA922238B (en) | 1993-09-27 |
| AU658887B2 (en) | 1995-05-04 |
| EP0582643A1 (en) | 1994-02-16 |
| AU1779692A (en) | 1992-11-02 |
| DE9290035U1 (de) | 1993-11-18 |
| IL101325A0 (en) | 1992-11-15 |
| FI934222A0 (fi) | 1993-09-27 |
| HU9302728D0 (en) | 1993-12-28 |
| JPH06500793A (ja) | 1994-01-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5866578A (en) | Substituted pyrimidines for control of diabetic complications | |
| JP3906935B2 (ja) | Ｎ−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法 | |
| HU194186B (en) | Process for producing 2-amino-5-hydroxy-4-methyl-pyridine derivatives | |
| AU4507701A (en) | 3-thiazol-4-yl-pyprolidine derivatives as amp-specific phosphodiesterase inhibitors | |
| KR870000787B1 (ko) | α-아릴-4-(4,5-디히드로-3,5-디옥소-1,2,4-트리아진-2(3H)-일) 벤젠아세토니트릴의 제조방법 | |
| DE69108913T2 (de) | 4-alkylimidazolderivate. | |
| JP2005509632A (ja) | プロスタグランジンｅｐ２及び／又はｅｐ４受容体のリガンドとしてのポリアゾリジノン化合物 | |
| EP0434394B1 (en) | Compounds for treating inflammatory bowel disease | |
| JPS5940388B2 (ja) | ヒダントイン誘導体治療剤 | |
| HU199839B (en) | Process for producing new 1',2'-dihydro-spiro square brackets open imidazolidine-4,4'(3'h)-quinoline square brackets closed derivatives and pharmaceutical compositions comprising same as active ingredient | |
| US5703108A (en) | Bone deposition by certain prostaglandin agonists | |
| JP2007510741A (ja) | ナトリウムチャンネル遮断薬としての置換トリアゾール類 | |
| HUT67836A (en) | Pyridazinone acetic acids having aldose reductase inhibitory activity, pharmaceutical compositions containing them and process for preparation of them | |
| JPH0536436B2 (enExample) | ||
| JP2011510009A (ja) | 緑内障、高眼圧、禿頭症及び脱毛症の治療用ベータラクタム | |
| DE69625795T2 (de) | Thiazolidinedionderivate mit antidiabetischen, hypolipidämischen und antihypertensiven Eigenschaften, Verfahren zu deren Herstellung und pharmazeutischen Zusammenstellungen, die sie enthalten | |
| JPH03193747A (ja) | ２―ヒドロキシ―３―フエノキシプロピルアミノ化合物、該化合物を含有する肥満症及び類縁症状の治療用薬剤学的組成物、該化合物の製造方法、及び中間体 | |
| JP4117462B2 (ja) | ナフチリジンおよびキノリン誘導体 | |
| US4304790A (en) | 2-(Alkylthio, alkylsulfinyl or alkylsulfonyl)-4-[2-anilinoalkylamino)-1-hydroxyethyl]phenols and derivatives thereof | |
| DE19711617A1 (de) | Neue Thiazolidindione, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel | |
| US4748164A (en) | Bicyclic benzonoid alkylene amino thieno [3,4-D] isothiazole ethers and thioethethers, pharmaceutical compositions and use | |
| JP2001520661A (ja) | 複素環式化合物並びにその調製及び利用 | |
| US4699906A (en) | Bicyclic benzenoid alkylene amino thieno[3,4-d]isothiazole ethers and thioethers, pharmaceutical compositions and use | |
| KR100388506B1 (ko) | 배뇨장애의 예방·치료제 | |
| JPH0386868A (ja) | ピリダジノン化合物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFD9 | Temporary protection cancelled due to non-payment of fee |